NewAmsterdam Pharma (NAMS) Shares Outstanding (Diluted) (2021 - 2026)
NewAmsterdam Pharma (NAMS) recorded Weighted Average Shares Outstanding (Diluted) of 123.37 million in Q2 2026, up 4.1% from 118.56 million a year earlier and up 1.4% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
For FY2025, NewAmsterdam Pharma reported Weighted Average Shares Outstanding (Diluted) of 118.42 million, up 25.5% from FY2024.
- Annual Weighted Average Shares Outstanding (Diluted) has increased for five straight years, with a five-year compound annual growth rate of 61.9% (FY2020 to FY2025).
- Across earlier years, Weighted Average Shares Outstanding (Diluted) came in at 94.36 million in FY2024 (+14.8%), 82.16 million in FY2023 (+333.2%), 18.97 million in FY2022 (+67.5%) and 11.33 million in FY2021 (+6.3%).
- The Q2 2026 figure is the highest quarterly Weighted Average Shares Outstanding (Diluted) in data going back to Q4 2021.
- On a year-over-year basis, Weighted Average Shares Outstanding (Diluted) has increased for 11 consecutive quarters, with growth averaging 18.3% over the last eight quarters.
- Across the past five years, year-over-year growth in Weighted Average Shares Outstanding (Diluted) ran from 4.1% in Q2 2026 to 624.6% in Q2 2023.
- Per Business Quant, the preceding three quarters came in at 121.72 million (Q1 2026), 118.42 million (Q4 2025) and 119 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | NewAmsterdam Pharma | 2.30 Bn | -236.30 Mn | - | 124.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 124.14 Mn |
| Jun 30, 2026 | 123.37 Mn |
| Mar 31, 2026 | 121.72 Mn |
| Dec 31, 2025 | 118.42 Mn |
| Sep 30, 2025 | 119.00 Mn |
| Jun 30, 2025 | 118.56 Mn |
| Mar 31, 2025 | 116.12 Mn |
| Dec 31, 2024 | 94.36 Mn |
| Sep 30, 2024 | 94.75 Mn |
| Jun 30, 2024 | 94.71 Mn |
| Mar 31, 2024 | 88.38 Mn |
| Dec 31, 2023 | 82.16 Mn |
| Sep 30, 2023 | 82.47 Mn |
| Jun 30, 2023 | 82.06 Mn |
| Mar 31, 2023 | 81.63 Mn |
| Dec 31, 2022 | 18.97 Mn |
| Jun 30, 2022 | 11.33 Mn |
| Dec 31, 2021 | 11.33 Mn |
API Access
NewAmsterdam Pharma Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();